A Study of Tasisulam in Treating Participants With Malignant Melanoma

Clinical trial NCT00383292 · COMPLETED

Trial details

NCT number: NCT00383292
Sponsor: Eli Lilly and Company
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Metastatic Melanoma

Start date: 2006-11-01
Primary completion: 2011-09-01
Enrollment: 130

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.